AU2012101550B4 - Composition - Google Patents
Composition Download PDFInfo
- Publication number
- AU2012101550B4 AU2012101550B4 AU2012101550A AU2012101550A AU2012101550B4 AU 2012101550 B4 AU2012101550 B4 AU 2012101550B4 AU 2012101550 A AU2012101550 A AU 2012101550A AU 2012101550 A AU2012101550 A AU 2012101550A AU 2012101550 B4 AU2012101550 B4 AU 2012101550B4
- Authority
- AU
- Australia
- Prior art keywords
- composition
- weight
- zinc
- sodium
- climbazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 229920000642 polymer Polymers 0.000 claims abstract description 13
- 125000002091 cationic group Chemical group 0.000 claims abstract description 12
- 244000007835 Cyamopsis tetragonoloba Species 0.000 claims abstract description 11
- 230000008021 deposition Effects 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- 230000000855 fungicidal effect Effects 0.000 claims abstract description 8
- 239000000417 fungicide Substances 0.000 claims abstract description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000011701 zinc Substances 0.000 claims abstract description 7
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 7
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 claims description 10
- 229960003344 climbazole Drugs 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000002453 shampoo Substances 0.000 claims description 6
- 229940043810 zinc pyrithione Drugs 0.000 claims description 6
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 claims description 6
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 claims description 4
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims description 3
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims description 3
- 229960004125 ketoconazole Drugs 0.000 claims description 3
- 239000002304 perfume Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 229910021653 sulphate ion Inorganic materials 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 claims description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 claims description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 229940073499 decyl glucoside Drugs 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 229940100608 glycol distearate Drugs 0.000 claims description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 claims description 2
- 229940081510 piroctone olamine Drugs 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 2
- 229960004025 sodium salicylate Drugs 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000368 sulisobenzone Drugs 0.000 claims description 2
- 230000003750 conditioning effect Effects 0.000 description 4
- 208000001840 Dandruff Diseases 0.000 description 2
- 241000282372 Panthera onca Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 102100035353 Cyclin-dependent kinase 2-associated protein 1 Human genes 0.000 description 1
- 101710176410 Cyclin-dependent kinase 2-associated protein 1 Proteins 0.000 description 1
- 101710126767 Filamin A-interacting protein 1-like Proteins 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- -1 hydroxypropyl Chemical group 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
C:WRPonbl\DCC\SM4679323_1 DOC-0/1612012 COMPOSITION 5 Hair treatment composition comprising a zinc-based antidandruff agent, a conazole fungicide and a cationic modified guar deposition polymer.
Description
Our Ref: 35115315 P/00/011 Regulation 3:2 AUSTRALIA Patents Act 1990 ORIGINAL COMPLETE SPECIFICATION INNOVATION PATENT Applicant(s): Unilever PLC Unilever House, 100 Victoria Embankment, London, Greater London EC4Y ODY, United Kingdom Address for Service: DAVIES COLLISON CAVE Patent & Trade Mark Attorneys 255 Elizabeth Street SYDNEY NSW 2000 Invention Title: "Composition" The following statement is a full description of this invention, including the best method of performing it known to me:- C:\NRPortbIlDCC\SJf\4679323_1 DOC-10/16/2D12 COMPOSITION The present invention relates to a hair treatment composition comprising anti dandruff agents and a cationic deposition polymer. 5 DE 101 11 288 (Wella) discloses a composition comprising climbazole, zinc pyrithione and Polyquaternium-10. Despite the prior art there remains the need for improved anti-dandruff 10 compositions. Accordingly, the present invention provides a hair treatment composition comprising a zinc-based antidandruff agent, a conazole fungicide and a cationic modified guar deposition polymer. 15 Preferably, the zinc-based antidandruff agent is zinc pyrithione. Preferably, the zinc-based antidandruff agent is present at from 0.01 to 2% wt. of the composition. More preferably it is present at from 0.5 to 1.5 and most 20 preferably from 0.75 to 1.25% wt. of the composition. Preferably, the conazole fungicide is selected from ketoconazole and climbazole. Preferably, the conazole fungicide is present at from 0.01 to 2% wt. of the 25 composition. More preferably it is present at from 0.025 to 0.75% wt. of the composition. Such cationic deposition polymers may be a homopolymer or be formed from two or more types of monomers. The molecular weight of the polymer will generally 30 be between 5 000 and 10 000 000 unified atomic mass units, typically at least 10 000 and preferably from 100 000 to 2 000 000. The polymers will have cationic nitrogen containing groups such as quaternary ammonium or protonated amino groups, or a mixture thereof. A suitable cationic deposition polymer is AQU D4051 C:\MRPort\DCCSm4679323_1 DOC-1)/16121112 -2 a cationically-modified guar commercially available from Aqualon. Preferably, the cationic deposition polymer is guar hydroxypropyl trimonium chloride. 5 It is highly preferred that compositions according to the invention should contain from 0.04% to 2% wt. of the composition cationic deposition polymer, more preferably from 0.05 to 0.5% wt. and most preferably from 0.08 to 0.25% by weight of the composition. 10 According to another aspect the present invention provides a hair treatment composition comprising from 0.01 to 1.5% of a zinc-based antidandruff agent by weight of the composition, from 0.01 to 0.75% of a conazole fungicide by weight of the composition, and from 0.04 to 2% of a cationic modified guar deposition 15 polymer by weight of the composition, wherein the conazole fungicide is selected from ketoconazole and climbazole, with the proviso that the composition is not a shampoo consisting of: - 12 wt.% of sodium laureth sulphate; - 4 wt% of cocoamidopropyl betaine; 20 - 3 wt.% of decyl glucoside; - 0.2 wt% of polyquaternium-7; - 0.3 wt.% of guar hydroxypropyl trimonium chloride; - 0.5 wt.% of PEG-40 hydrogenated castor oil; - 1 wt.% of glycol distearate; 25 - 2 wt.% of urea; - 3.75 wt.% Polysaf 5600 (40% dispersion); - 0.2 wt.% of sodium salicylate; - 0.5 wt.% of zinc pyrithione; - 0.5 wt. of sodium benzoate; 30 - 2 wt.% of cocamide DEA; - 0.3 wt.% of Coolact 10; - 0.3 wt.% of Benzophenone-4; - 0.3 wt.% of oryzanol; CANRPonbR\DCCSMT4679323_1 DOC-1W16/2012 -3 - 0.5 wt.% of climbazole; - 0.3 wt.% of piroctone olamine; - q.s.of caustic soda solution, perfume, citric acid, and sodium chloride; and 5 - balance of water. The composition according to the invention may be in any common product form used to treat hair. However, preferably, it is shampoo composition. io The composition according to the invention may comprise any of the ingredients commonly found in hair treatment compositions depending on the product form. For example, where the composition is a shampoo it will comprise at least one cleansing surfactant such as is commonly employed in shampoos. Where it is a 15 composition which aims to provide conditioning benefit, whether as part of a shampoo composition or a dedicated conditioning composition it will comprise a conditioning active. Suitable conditioning actives include fatty alcohols, silicones and cationic surfactants. 20 EXAMPLE I The following formulation is an embodiment of the invention and is made by standard processes. Ingredient % wt. Sodium Laureth Sulphate 14 Cocoamidopropyl betaine 1.6 Guar hydroxypropyl trimonium 0.2 chloride* Zinc Pyrithione 1.0 Climbazole 0.5 Zinc sulphate 0.1 CWRPortbl\DCC\SJTn679323 DOC.10/6/2011 Dimethicone 2.0 Perfume 0.7 Sodium chloride 0.5 Propylene Glocol 1.0 Acrylic Acid polymer (Carbomer) 0.6 Polypropylene Glycol 0.1 Preservative 0.22 Preservative 0.09 Water To 100 * Jaguar C17 EXAMPLE 2 5 The following demonstrates the efficacy of climbazole in the presence of cationic guar and polyquaternium-1 0. Test sample Conc. ZPTO p/cm3 after S.D. one rinse (two rinses) 1% ZPTO, 0.5% 15.51 (12.199) 1.35 (1.456) climbazole, 0.2% Jaguar C17 1% ZPTO, 0.5% 12.39 (7.49) 1.11 (0.57) climbazole, 0.2% PQ-10 io Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps. 15 The reference in this specification to any prior publication (or information derived C:XWRPorbl\DCC\ST\4679323 1 DOC-10/16/2012 -5 from it), or to any matter which is known, is not, and should not be taken as, an acknowledgement or admission or any form of suggestion that that prior publication (or information derived from it) or known matter forms part of the common general knowledge in the field of endeavour to which this specification 5 relates.
Claims (5)
1. Hair treatment composition comprising from 0.01 to 1.5% of a zinc-based antidandruff agent by weight of the composition, from 0.01 to 0.75% of a 5 conazole fungicide by weight of the composition, and from 0.04 to 2% of a cationic modified guar deposition polymer by weight of the composition, wherein the conazole fungicide is selected from ketoconazole and climbazole, with the proviso that the composition is not a shampoo consisting of: 10 - 12 wt.% of sodium laureth sulphate; - 4 wt% of cocoamidopropyl betaine; - 3 wt.% of decyl glucoside; - 0.2 wt% of polyquaternium-7; - 0.3 wt.% of guar hydroxypropyl trimonium chloride; is - 0.5 wt.% of PEG-40 hydrogenated castor oil; - 1 wt.% of glycol distearate; - 2 wt.% of urea; - 3.75 wt.% Polysaf 5600 (40% dispersion); - 0.2 wt.% of sodium salicylate; 20 - 0.5 wt.% of zinc pyrithione; - 0.5 wt. of sodium benzoate; - 2 wt.% of cocamide DEA; - 0.3 wt.% of Coolact 10; - 0.3 wt.% of Benzophenone-4; 25 - 0.3 wt.% of oryzanol; - 0.5 wt.% of climbazole; - 0.3 wt.% of piroctone olamine; - q.s.of caustic soda solution, perfume, citric acid, and sodium chloride; and 30 - balance of water.
2. Composition according to claim 1 wherein the zinc-based antidandruff agent is zinc pyrithione. C-\JRPerbl\DCCSJf4679323. LDOC-II1/I6/2012 -7
3. Composition according to claim 1 or claim 2 wherein the polymer is guar hydroxypropyl trimonium chloride. 5
4. Composition according to any one of claims 1 to 3 wherein the composition comprises from 0.04 to 0.25% of the cationic modified guar deposition polymer by weight of the composition.
5. A hair treatment composition substantially as hereinbefore described with 0 o reference to the examples.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012101550A AU2012101550B4 (en) | 2009-05-08 | 2012-10-16 | Composition |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09159807.8 | 2009-05-08 | ||
| AU2010244577A AU2010244577B2 (en) | 2009-05-08 | 2010-04-12 | Composition |
| AU2012101550A AU2012101550B4 (en) | 2009-05-08 | 2012-10-16 | Composition |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2010244577A Division AU2010244577B2 (en) | 2009-05-08 | 2010-04-12 | Composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2012101550A4 AU2012101550A4 (en) | 2012-11-22 |
| AU2012101550B4 true AU2012101550B4 (en) | 2013-05-02 |
Family
ID=47190235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012101550A Expired AU2012101550B4 (en) | 2009-05-08 | 2012-10-16 | Composition |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2012101550B4 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10111288A1 (en) * | 2001-03-09 | 2002-09-12 | Wella Ag | Anti-dandruff agents |
| US20070110700A1 (en) * | 2002-06-04 | 2007-05-17 | Wells Robert L | Shampoo containing a gel network |
| WO2009138194A1 (en) * | 2008-05-13 | 2009-11-19 | Beiersdorf Ag | Cosmetic preparations against dandruff |
-
2012
- 2012-10-16 AU AU2012101550A patent/AU2012101550B4/en not_active Expired
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10111288A1 (en) * | 2001-03-09 | 2002-09-12 | Wella Ag | Anti-dandruff agents |
| US20070110700A1 (en) * | 2002-06-04 | 2007-05-17 | Wells Robert L | Shampoo containing a gel network |
| WO2009138194A1 (en) * | 2008-05-13 | 2009-11-19 | Beiersdorf Ag | Cosmetic preparations against dandruff |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012101550A4 (en) | 2012-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010244577B2 (en) | Composition | |
| US10463597B2 (en) | Personal care composition | |
| EP3134182B1 (en) | Method of inhibiting copper deposition on hair | |
| EP3134066B1 (en) | Method of inhibiting copper deposition on hair | |
| MX2014008328A (en) | Hair care compositions. | |
| EP3644951A1 (en) | Hair care compositions comprising a 2-pyridinol-n-oxide material and an iron chelator | |
| EP2937112B1 (en) | Method of inhibiting copper deposition on hair | |
| JP6911100B2 (en) | Antibacterial composition | |
| JP6900375B2 (en) | Hair care composition | |
| EP3703646B1 (en) | Antidandruff composition and method of use | |
| AU2012101550B4 (en) | Composition | |
| US20220401352A1 (en) | A cosmetic composition | |
| CN110325170A (en) | Hair care composition | |
| US20250032384A1 (en) | Hair care composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGI | Letters patent sealed or granted (innovation patent) | ||
| FF | Certified innovation patent | ||
| MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |